Discover Protalix BioTherapeutics' Q4 2024 earnings insights, including record revenues, pipeline advancements, and future growth prospects.

Protalix Biotherapeutics Inc（纳斯达克股票代码：PLX）发布2024年第四季度财报，总收入同比增长31%。尽管净利润有所下降，但公司创新产品线和战略合作伙伴关系增强了投资者信心，盘前股价上涨7.14%至$2.40。

Newsweek explored the reasons with a LGBTQ+ relationship expert and a woman who made the switch to a same-sex relationship.

Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, March 17, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...

100 x 80 cm. (39.4 x 31.5 in.) ...

ToI tours IDF's highest army post in Syria, overlooking Damascus and Hezbollah's Beqaa Valley stronghold in Lebanon; Syrian ...

Highlights: Trek through Chunjian’s tea-themed educational park to Bashan’s undulating plantations, featured in The Hunting ...

This major sporting event is organized by the Dazhou Municipal People's Government, with the Sichuan Athletic Association and the Dazhou Bureau of Culture, Sports, and Tourism serving as the hosting ...

Exciting news for marathon enthusiasts! The 2025 Dazhou Marathon, part of the "Run Across Sichuan" series, is set to take place on April 13th, and the registration will officially open on March 11th ...